HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Christopher Gasink  1     Edward V. Loftus Jr  2     Timothy Hoops  1     James Izanec  1     Tony Ma  1     Zhijie Ding  1     Erik Muser  3     Peter Irving     Matthieu Allez     William J. Sandborn     Remo Panaccione     Silvio Danese    
1 Janssen Scientific Affairs, LLC,Horsham,United States
2 Mayo Clinic College of Medicine,Rochester,United States
3 Jan

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing